Loading...
High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
BACKGROUND: This study was to evaluate the effect of excision repair cross-complementation group 1(ERCC1) expression on response to cisplatin-based induction chemotherapy (IC) followed by concurrent chemoradiation (CCRT) in locally advanced unresectable head and neck squamous cell carcinoma (HNSCC)...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3072326/ https://ncbi.nlm.nih.gov/pubmed/21426588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-31 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|